Evaluating high-dose biotin and insulin therapy in a dose-refined model of streptozotocin-induced type 1 diabetes
Comparative Clinical Pathology · 20.11.2026 · 35 (1)
DOI: 10.1007/s00580-026-03893-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Comparative Clinical Pathology, online erschienen am 20.11.2026. Verfasst von Lesya Yanitska und 7 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yanitska, L., Horkunenko, O., Yevstifeiev, D., Syrvatka, R., Kovalenko, Y., Sydorenko, V., Karpenko, A., & Kuchmerovska, T. (2026). Evaluating high-dose biotin and insulin therapy in a dose-refined model of streptozotocin-induced type 1 diabetes. Comparative Clinical Pathology, 35(1). https://doi.org/10.1007/s00580-026-03893-w
Vancouver
Yanitska L, Horkunenko O, Yevstifeiev D, Syrvatka R, Kovalenko Y, Sydorenko V, et al. Evaluating high-dose biotin and insulin therapy in a dose-refined model of streptozotocin-induced type 1 diabetes. Comparative Clinical Pathology. 2026;35(1). doi:10.1007/s00580-026-03893-w
BibTeX
@article{Yanitska2026,
author = {Yanitska, Lesya and Horkunenko, Oksana and Yevstifeiev, Danylo and Syrvatka, Roman and Kovalenko, Yulianna and Sydorenko, Viktoriia and Karpenko, Andrii and Kuchmerovska, Tamara},
title = {Evaluating high-dose biotin and insulin therapy in a dose-refined model of streptozotocin-induced type 1 diabetes},
journal = {Comparative Clinical Pathology},
year = {2026},
volume = {35},
number = {1},
doi = {10.1007/s00580-026-03893-w}
}
EUVIMED